Amneal Pharmaceuticals, Inc. - News - Press Releases

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Dec 18, 2006

IMPAX Announces FDA Approval of Generic Wellbutrin XL 300 mg

Nov 22, 2006

IMPAX Announces Court of Appeals Remands Earlier Riluzole Patent Validity Decision Back to Lower Court

Nov 10, 2006

IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg

Nov 03, 2006

IMPAX Receives FDA Approval for Generic Versions of Urecholine(R) Tablets

Oct 26, 2006

IMPAX Receives FDA Approval for Generic Version of Colestid(R) Tablets

Oct 09, 2006

IMPAX Appoints Grant Thornton as Principal Accountant

Oct 03, 2006

IMPAX Announces Dismissal of Lawsuit Related to Generic Concerta(R)

Sep 07, 2006

IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL

Jul 11, 2006

IMPAX Announces the Launch of IMPAX Pharmaceuticals; Company's Branded Products Division

Jun 29, 2006

IMPAX Settles Solvay Litigation

May 03, 2006

IMPAX Receives FDA Approval for Generic Version of Colestid(R); Global Pharmaceuticals Division to Launch

Apr 07, 2006

IMPAX Comments on Wyeth's Lawsuit Related to Generic Versions of Effexor XR(R)

Apr 05, 2006

IMPAX Receives FDA Approval for Generic Version of SALAGEN(R) Tablets; Global Pharmaceuticals Division to Launch

Mar 07, 2006

IMPAX Receives FDA Non-Approvable Letter for Vadova; Company to Request Meeting With FDA

Jan 19, 2006

IMPAX Settles Patent Suit and Signs Marketing and Promotion Agreements with Shire

Jan 18, 2006

ADDERALL XR(R) - Litigation Update

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.15.0.14